Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Agenda
Tratamientos adaptados al paciente
Exacerbaciones en la EPOC
SEPAR-ALAT
Abandono del tabaco, actividad fsica, vacunaciones
EP
OC
Ciruga
Broncodilatadores solos o en combinacin (tiotropio, salmeterol, formeterol y ms recientemente indacaterol Asociar broncodilatadores y glucocorticoides inhalados, rehabilitacin Teofilina Oxgeno domiciliario
leve
moderada
grave
muy grave
FEV1
Sntomas, tratamiento?
3
1959
Ciba Guest Symposium. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions: a report of the conclusions of a Ciba guest symposium. Thorax 1959;14:286 299 ATS: Is a disease state characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema; the airflow obstruction is generally progressive, may be acompanied by airway hyperreactivity and can be patially reversible ERS: Is a disorder characterized by reduced maximun expiratory flow and slow forced emptying of the lungs; features wich do not change markedely over several months. Most of the airflow limitation is slowly progressive and irreversible. The airflow limitation is due to varying combinations of airway disease and emphysema GOLD: Is a disease characterized by a progressive airflow limitation caused by an abnormal inflammatory reaction to the chronic inhalation of particles SEPAR: La EPOC se caracteriza por la presencia de obstruccin crnica y poco reversible al flujo areo (disminucin del FEV1, y de la relacin FEV1/FVC), y est causada, fundamentalmente, por una reaccin inflamatoria anmala frente al humo del tabaco
1995
2008
RESEARCH
Open Access
Alvar Agusti1*, Peter MA Calverley2, Bartolome Celli3, Harvey O Coxson4, Lisa D Edwards5, David A Lomas6, William MacNee7, Bruce E Miller8, Steve Rennard9, Edwin K Silverman10, Ruth Tal-Singer8, Emiel Wouters11, Julie C Yates5, Jrgen Vestbo12, the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
Conclusions: The clinical manifestations of COPD are highly variable and the degree of airflow limitation does not capture the heterogeneity of the disease.
5
Sobrediagnstico de EPOC